Literature DB >> 27169456

[Efficacy of levocarnitine for tyrosine kinase inhibitor-induced painful muscle cramps in patients with chronic myelogenous leukemia].

Michiko Yamada1, Hiroyuki Kuroda, Saori Shimoyama, Ryo Ito, Yusuke Sugama, Ken Sato, Natsumi Yamauchi, Hiroto Horiguchi, Hajime Nakamura, Kota Hamaguchi, Tomoyuki Abe, Shigeyuki Fujii, Masahiro Maeda, Junji Kato.   

Abstract

Muscle cramps are side effects commonly associated with tyrosine kinase inhibitor (TKI) treatment. Patients suffering from muscle cramps are treated with various medications such as calcium, magnesium and vitamin supplements, but these therapies are often ineffective. We report two patients with chronic myelogenous leukemia who developed muscle cramps caused by TKI. These patients were treated successfully with levocarnitine. Both of our cases revealed the beneficial effects of levocarnitine treatment on TKI-induced muscle cramps.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27169456     DOI: 10.11406/rinketsu.57.489

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  1 in total

1.  Impact of L-carnitine on imatinib-related muscle cramps in patients with gastrointestinal stromal tumor.

Authors:  Heejung Chae; Min-Hee Ryu; Jungeun Ma; Moyeol Beck; Yoon-Koo Kang
Journal:  Invest New Drugs       Date:  2019-10-18       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.